The most recent Form 13F filing that Russell Investments Group Ltd. made with the SEC reveals that during the third quarter of 2018, the firm increased the percentage of HCA Healthcare, Inc. (NYSE: HCA) shares that it owned by 17.3%. The mutual fund finished the period with a total holding of 809,482 shares of the company’s stock, which was accomplished by purchasing an additional 119,648 shares of the company’s stock throughout the quarter. According to the most recent filing that Russell Investments Group Ltd. made with the SEC, the company’s holdings in HCA Healthcare amount to approximately 0.28% of the company and are estimated to be worth approximately $148,886,000.
Several other institutional investors and hedge funds have been involved in recent transactions involving purchasing and selling HCA shares. HCA carried out these transactions. Lincoln National Corporation completed the purchase of an additional 11.7% stake in HCA Healthcare during the third quarter. Following the acquisition of 1,072 shares during the period in question, Lincoln National Corp. now holds 10,203 shares of the company’s stock. The market value of these shares is currently equal to $1,875,000. Ieq Capital LLC’s ownership stake in HCA Healthcare increased by 77.6% during the third quarter due to the company’s continued expansion. Ieq Capital LLC now holds 4,250 shares of the company’s stock following the acquisition of an additional 1,857 shares during the most recent quarter. Each share of the company’s stock is currently valued at $781,000. During the third quarter, First Republic Investment Management Inc. brought the amount of HCA Healthcare stock it owned to a level that was 1.2% higher than before. First Republic Investment Management Inc. now holds 287,102 shares, valued at $52,767,000, after purchasing an additional 3,518 shares during the most recent quarter. CIBC Asset Management Inc. increased the proportion of HCA Healthcare stock owned by 1.6% during the third quarter. CIBC Asset Management Inc. now has a total of 33,284 shares following purchasing of an additional 524 shares during the preceding quarter. The current value of these shares is $6,117,000.
Last but not least, during the third quarter, SRS Capital Advisors Inc. increased the percentage of HCA Healthcare stock owned by 6.2%. This certainly should not be considered the least important development. SRS Capital Advisors Inc. now owns 1,266 shares after purchasing 74 additional shares during the most recent quarter. The company’s shares are currently valued at a combined total of $234,000. Various hedge funds and other types of institutional investors hold a total of 64.60 percent of the company’s shares.
Research analysts have penned multiple reports on the subject of HCA. These reports can be found here. UBS Group released the findings of a research study on Friday, January 13, which indicated that the company had upgraded the stock’s rating to “buy” and increased their price target on shares of HCA Healthcare from $237.00 to $296.00. In a report published on Wednesday, October 26, Citigroup raised its price target on HCA Healthcare shares from $240.00 to $251.00, giving the stock a “buy” rating. Credit Suisse Group stated that they would be decreasing their price target on shares of HCA Healthcare to $240.00 in a research report published on October 27. Goldman Sachs Group moved HCA Healthcare from a “hold” rating to a “buy” rating and raised their price target for the stock in a research report released on Monday, December 12. The report was published online. In a report released on Tuesday, January 3, Wells Fargo & Company upgraded their price objective on shares of HCA Healthcare from $217.00 to $243.00 and rated the stock as “equal weight.” One research analyst rated the stock as “sell,” while another rated it as “hold.” Fifteen research analysts have recommended buying the stock, and one analyst has recommended a “strong buy.” According to the information that Bloomberg provided, the company currently has a “Moderate Buy” average rating and a price objective of $250.25. On November 11, Bruce Moore, Jr., an insider at HCA Healthcare, sold 10,000 shares of the company’s stock. The transaction took place that day. A total of $2,240,700.00 was received from the sale of the shares, which came out to an average price of $224.07 per share. The company insider currently possesses 30,807 company shares, which have a combined value of approximately $6,902,924.49. Should you follow this link, you will be taken to the SEC filing in which the transaction was discussed in greater detail. A. Bruce Moore, Jr., an employee of the company who is considered an insider, sold a total of 10,000 shares of the company’s stock on Friday, November 11. A total of $2,240,700.00 was received from the sale of the shares, which came out to an average price of $224.07 per share. As a direct consequence of the acquisition, the company insider now possesses 30,807 shares of the company, which have a total value of $6,902,924.49. On the Securities and Exchange Commission (SEC) website, you can currently access the information concerning the sale that was submitted to the SEC. Additionally, on Monday, October 24, Senior Vice President Kathryn A. Torres sold 2,000 of the company’s shares of stock. This transaction took place. A total of 405 shares worth $406,600.00 were sold at an average price of $203.30 per share. The sale generated this amount. The average price per share was 203.30 dollars. As a result of the successful completion of the transaction, the senior vice president is now the owner of 20,372 company shares, which have a combined value of $4,141,627.60. Disclosures that are related to the sale might be found in this section of the website. Business insiders sold 30,170 shares of company stock during the most recent fiscal period, resulting in a total transaction value of $6,700,630. 1.50 company insiders own a percent of the total shares currently outstanding.
The price of a share of HCA Healthcare Corporation’s stock increased by $4.42 during the morning session on Friday, reaching a price of $261.40. The total volume of transactions for the company’s stock was 1,241,201 shares, while the average volume was 949,895. The stock price has maintained a moving average of $241.98 over the past 50 days, while over the past 200 days, that figure has decreased to $216.68. During the past year, the share price of HCA Healthcare, Inc. has fluctuated between $164.47 and $279.02, hitting a low of $164.47 and a high of $279.02. The company has a price-to-earnings-growth ratio of 1.98, a price-to-earnings-growth ratio of 14.77, and a beta value of 1.65, all of which contribute to its current market capitalization of $73.90 billion.
On Friday, October 21, HCA Healthcare (NYSE: HCA) announced the release of its most recent quarterly results report and made it available to the general public. The company reported that its quarterly earnings per share came in at $3.93, which is $0.04 higher than the consensus estimate of $3.89 provided by market analysts. The return on equity for HCA Healthcare was calculated to be 118,372.40%, and the net margin for the company was 8.99%. Although analysts predicted that the company would bring in $15 billion in revenue for the quarter, it only brought in $14.97 billion in revenue for the period in question. The company generated earnings of $4.57 per share during the same period in the prior year’s operations. Compared to the same time period in the prior year, HCA Healthcare experienced a decrease of 2.0% in the amount of revenue it brought in during the third quarter. According to projections made by analysts who follow the stock market, HCA Healthcare, Inc. is expected to generate earnings of $16.96 per share in 2018.
HCA Healthcare, Inc. manages a nationwide system of healthcare facilities through its various wholly-owned subsidiaries, including hospitals and medical clinics. Not only does the own company hospitals, but it also manages both general and acute-care facilities in those hospitals. In addition to offering outpatient services such as surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy, these hospitals also provide inpatient, intensive, cardiac, diagnostic, and emergency care. In addition to that, they offer treatment for patients in critical situations.
